Yu-Waye Chu Insider Profile
11 Followers
Yu-Waye Chu, CMO at CytomX Therapeutics, holds 189.45K shares in CytomX Therapeutics (Ticker: CTMX), holds 140.68K shares in Fate Therapeutics (Ticker: FATE). Most recently, Yu-Waye Chu Sold ― shares of CytomX Therapeutics on Mar 19, 2026 for an estimated value of $136.61K.
Profitable Transactions
6 out of 7 Profitable Transactions
Average Return
-39.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Yu-Waye Chu
Yu-Waye Chu's Trading History
CytomX Therapeutics
Mar 19, 2026
CMO
Informative Sell
136.61K
$702.84K
Fate Therapeutics
Apr 19, 2023
CMO
Informative Sell
16.65K
$348.88K
List of latest transactions for each holding click on a transaction to see Yu-Waye Chu's performance on stock
You May Also Like
Yu-Waye Chu insider profile FAQ
What is the percentage of profitable transactions made by Yu-Waye Chu?
The percentage of profitable transactions made by Yu-Waye Chu is 86%.
What is the average return per transaction made by Yu-Waye Chu?
The average return per transaction made by Yu-Waye Chu is -39.60%.
What stocks does Yu-Waye Chu hold?
Yu-Waye Chu holds: CTMX, FATE stocks.
What was Yu-Waye Chu’s latest transaction?
Yu-Waye Chu latest transaction was an Informative Sell of $136.61K.
What was Yu-Waye Chu's most profitable transaction?
Yu-Waye Chu’s most profitable transaction was an Informative Sell of FATE stock on January 13, 2022. The return on the trade was 87.20%.
What is Yu-Waye Chu's role in CytomX Therapeutics?
Yu-Waye Chu's role in CytomX Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.